Vitamin D and Glaucoma: A Critical Review of the Literature

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Agent</td><td class="align_center">Half-life</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">Vitamin D2 (ergocalciferol)</td><td class="align_center" rowspan="2">3–4 days</td></tr><tr><td class="align_left">Vitamin D3 (cholecalciferol)</td></tr><tr><td class="align_left">25(OH)D2 (ercalcidiol)</td><td class="align_center">14 days</td></tr><tr><td class="align_left">25(OH) D3 (calcifediol/calcidiol)</td><td class="align_center">30 days</td></tr><tr><td class="align_left">1,25(OH)<sub>2</sub>D (calcitriol)</td><td class="align_center">7–10 h</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Vitamin D agents and half-lifes.</div>

Journal of Ophthalmology

tab1

Table 1

Table 1: Vitamin D and Glaucoma: A Critical Review of the Literature 